AI-generated summary
This review examines how radiodermatitis, a skin reaction in patients receiving radiotherapy for cancer, can be prevented or managed. The authors note there is insufficient evidence for recommendations to prevent or reduce it. They report that low level light therapy and vascular lasers have been used to control symptoms, and that pulsed dye laser treatment has been shown to be beneficial for radiation-induced telangiectasia.
- Who or what was studied
- Patients with cancer treated with radiotherapy who develop radiodermatitis
- Limits stated in the abstract
- The authors state there is insufficient evidence to form recommendations, and treatment of radiodermatitis is described as being in its infancy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.